DUVOID Drug Patent Profile
✉ Email this page to a colleague
When do Duvoid patents expire, and when can generic versions of Duvoid launch?
Duvoid is a drug marketed by Chartwell Rx and is included in three NDAs.
The generic ingredient in DUVOID is bethanechol chloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duvoid
A generic version of DUVOID was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUVOID?
- What are the global sales for DUVOID?
- What is Average Wholesale Price for DUVOID?
Summary for DUVOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 1,356 |
| DailyMed Link: | DUVOID at DailyMed |
US Patents and Regulatory Information for DUVOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 086262-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 086263-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 085882-003 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
